Right isomerism Advocacy Hub | UniteRare

At a Glance

Live from database

🩺

2Specialists

Regulatory Watchboard

5 events

Mar 2023Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

Massachusetts General Hospital — PHASE2

TrialRECRUITING

Feb 2023A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer

Memorial Sloan Kettering Cancer Center

TrialRECRUITING

Feb 2022I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer

Miami Cancer Research Center, Inc.

TrialRECRUITING

Jul 2020CASE 1320: RAI Uptake and Serum Prolactin in Thyroid Cancer

The Cleveland Clinic

TrialACTIVE NOT RECRUITING

Jul 2017RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers

Memorial Sloan Kettering Cancer Center — EARLY_PHASE1

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Right isomerism.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Right isomerism.
Search all trials →

Search clinical trials for Right isomerism →

Recent News & Research

No recent news articles indexed yet for Right isomerism.
Search PubMed for Right isomerism →

Browse all Right isomerism news →

Specialist Network

Top 2 by expertise

Stephanie M. Ware, MD, PhD

Indiana University School of Medicine

Score 31 trial

Hung Hin Brian Lang

The University of Hong Kong

Score 01 trial

View all Right isomerism specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰